Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Lack of association between cytotoxic T-lymphocyte antigen 4 (CTLA-4) -1722T/C (rs733618) polymorphism and cancer risk: from a case-control study to a meta-analysis.

Tang W, Qiu H, Jiang H, Sun B, Wang L, Yin J, Gu H.

PLoS One. 2014 Apr 7;9(4):e94039. doi: 10.1371/journal.pone.0094039. eCollection 2014.

2.

-1722T/C polymorphism (rs733618) of CTLA-4 significantly associated with systemic lupus erythematosus (SLE): a comprehensive meta-analysis.

Liu J, Zhang H.

Hum Immunol. 2013 Mar;74(3):341-7. doi: 10.1016/j.humimm.2012.12.009. Epub 2012 Dec 20.

PMID:
23261408
3.

CTLA-4 -1722T/C polymorphism and systemic lupus erythematosus susceptibility: a meta-analysis involving ten separate studies.

Zhu JM, Li BK, Chen GM, Feng CC, Cen H, Fan YG, Wang B, Pan HF, Ye DQ.

Immunol Invest. 2013;42(2):91-105. doi: 10.3109/08820139.2012.724752.

PMID:
23323522
4.

Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.

Liang J, Zhang S, Luo Q, Li W, Tian X, Zhang F, Zhao T, Chen X, Zhang X.

Gene. 2015 Sep 1;568(2):196-202. doi: 10.1016/j.gene.2015.05.051. Epub 2015 May 24.

PMID:
26013045
5.

The association of CTLA-4 A49G polymorphism with colorectal cancer risk in a Chinese Han population.

Wang Y, Wang X, Zhao R.

Int J Immunogenet. 2015 Apr;42(2):93-9. doi: 10.1111/iji.12181. Epub 2015 Feb 16.

PMID:
25689638
6.

Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.

Geng R, Song F, Yang X, Sun P, Hu J, Zhu C, Zhu B, Fan W.

Tumour Biol. 2014 Apr;35(4):3627-39. doi: 10.1007/s13277-013-1480-x. Epub 2013 Dec 5.

PMID:
24307627
7.

Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.

Xia W, Shi R, Zheng WL, Ma WL.

Technol Cancer Res Treat. 2013 Dec;12(6):565-74. doi: 10.7785/tcrt.2012.500350. Epub 2013 Jun 6.

PMID:
23745791
8.

Association between CTLA-4 polymorphisms and susceptibility to Celiac disease: a meta-analysis.

Song GG, Kim JH, Kim YH, Lee YH.

Hum Immunol. 2013 Sep;74(9):1214-8. doi: 10.1016/j.humimm.2013.05.014. Epub 2013 Jun 12.

PMID:
23770251
9.

Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis.

Chen Z, Fei M, Fu D, Zhang L, Ma Y, Wang Y, Zhang F, Xia Q, Wang X.

Gene. 2013 Mar 10;516(2):263-70. doi: 10.1016/j.gene.2012.12.030. Epub 2012 Dec 19. Review.

PMID:
23261825
10.

[Association between CTLA-4 gene polymorphism and susceptibility to cervical cancer].

Li H, Zhou YF, Guo HY, Sun T, Zhang WH, Lin DX.

Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):681-4. Chinese.

PMID:
22340049
11.

A meta-analysis of the association between the hOGG1 Ser326Cys polymorphism and the risk of esophageal squamous cell carcinoma.

Zhang J, Zhou J, Zhang P, Wang W, Tao S, Wang M.

PLoS One. 2013 Jun 6;8(6):e65742. doi: 10.1371/journal.pone.0065742. Print 2013.

12.

Association between Cytotoxic T-lymphocyte antigen 4 (CTLA-4) +49 G>A (rs231775) polymorphism and esophageal cancer: from a case-control study to a meta-analysis.

Liu C, Wang Y, Jiang H, Tang W, Chen S, Kang M, Dong C, Gu H.

Int J Clin Exp Med. 2015 Oct 15;8(10):17664-73. eCollection 2015.

13.

Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.

Zhang C, Hou WH, Ding XX, Wang X, Zhao H, Han XW, Wang WJ.

Asian Pac J Cancer Prev. 2016;17(8):3785-91.

14.

MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population.

Wei J, Zheng L, Liu S, Yin J, Wang L, Wang X, Shi Y, Shao A, Tang W, Ding G, Liu C, Chen S, Gu H.

Hum Immunol. 2013 Sep;74(9):1199-205. doi: 10.1016/j.humimm.2013.06.012. Epub 2013 Jun 17.

PMID:
23792053
15.

CTLA-4 SNPs (CT60A/G, -1722T/C, -1661G/A, and -318C/T) and systemic lupus erythematosus: a meta-analysis.

Zhu Y, Wang J, Feng X.

Crit Rev Eukaryot Gene Expr. 2014;24(2):89-100.

PMID:
24940764
16.

Strong association of CTLA-4 variation (CT60A/G) and CTLA-4 haplotypes with predisposition of Iranians to head and neck cancer.

Erfani N, Haghshenas MR, Hoseini MA, Hashemi SB, Khademi B, Ghaderi A.

Iran J Immunol. 2012 Sep;9(3):188-98.

17.

[The association of XRCC2 gene polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in China].

Wang N, Dong XJ, Li Y, Guo W, Zhou RM, Zhang XJ, Wang SJ.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Oct;24(5):538-43. Chinese.

PMID:
17922422
18.

Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population.

Bharti V, Mohanti BK, Das SN.

Hum Immunol. 2013 Mar;74(3):348-52. doi: 10.1016/j.humimm.2012.12.008. Epub 2012 Dec 12.

PMID:
23246583
19.

Lack of association between CTLA-4 and PDCD1 polymorphisms and acute rejection in German liver transplant recipients.

Thude H, Schipler AD, Treszl A, Peine S, Koch M, Sterneck M, Nashan B.

Hum Immunol. 2013 Aug;74(8):1041-5. doi: 10.1016/j.humimm.2013.04.021. Epub 2013 Apr 27.

PMID:
23628397
20.

Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.

Gao X, Zhang S, Qiao X, Yao Y, Wang L, Dong D, Ma X, Wang T.

Cancer Biomark. 2014;14(4):287-94. doi: 10.3233/CBM-140403.

PMID:
24934372

Supplemental Content

Support Center